HUTCHMED DRC Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

HUTCHMED DRC Stock Summary

HUTCHMED DRC competes with Collegium Pharmaceutical, Evotec SE, I Mab, Legend Biotech, and Neurocrine Biosciences. HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchmed China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2110 people.

HUTCHMED DRC Key Financial Ratios

HUTCHMED DRC Key Balance Sheet Accounts

HUTCHMED DRC Key Income Statement Accounts

HUTCHMED DRC Key Cash Accounts

HUTCHMED Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining HUTCHMED DRC's current stock value. Our valuation model uses many indicators to compare HUTCHMED DRC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HUTCHMED DRC competition to find correlations between indicators driving HUTCHMED DRC's intrinsic value. More Info.HUTCHMED DRC is rated # 4 in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . At this time, HUTCHMED DRC's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value HUTCHMED DRC by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

HUTCHMED DRC Systematic Risk

Today, most investors in HUTCHMED DRC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various HUTCHMED DRC's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of HUTCHMED DRC growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of HUTCHMED DRC help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of HUTCHMED DRC. We use our internally-developed statistical techniques to arrive at the intrinsic value of HUTCHMED DRC based on widely used predictive technical indicators. In general, we focus on analyzing HUTCHMED Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build HUTCHMED DRC's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.